Mithras plate reader
The Mithras plate reader is a versatile and reliable instrument used for high-throughput analysis in life science research. It is designed to measure absorbance, fluorescence, and luminescence in multi-well microplates. The Mithras plate reader provides accurate and reproducible results, making it a valuable tool for a wide range of applications, including cell-based assays, enzyme activity measurements, and drug discovery screening.
Lab products found in correlation
9 protocols using mithras plate reader
Gal4DBD-NSL3 protein reporter assay
BRET Saturation Experiments in HEK-293 Cells
Redirected Lysis Assay for BiTE/Triplebody
% specific Lysis = 100*[RLU (sample) − RLU (background)] / [RLU (maximal lysis) − RLU (background)]
Quantification of IFN-β in VSV-infected HFFs
Dual-Glo Luciferase Assay Protocol
Antibody-Drug Conjugates Targeting IGF-1R
Example 23
The five IGF-1R antibodies were shown to be rapidly internalized into lysosomes and to have a lower binding capacity into acidic environments. In that respect, those Abs had all properties to be used as ADCs. Thus, the five chimeric anti-IGF-1R antibodies were coupled with three different compounds (G-13; E-13 and F-63). The drug antibody ratio of those ADCs was about 4. In order to evaluate the non specific cytotoxicity, an irrelevant chimeric antibody c9G4 was also coupled with those compounds at the same DAR. MCF-7 cells were incubated with increasing concentrations of each ADCs at 37° C. for 6 days in complete culture medium. Cell viability was assessed using a luminescent cell viability assay (CELLTITER-GLO®, PROMEGA®). Luminescent signal was read using a the Mithras plate reader (Berthold Technologies). The irrelevant chimeric antibody c9G4 coupled with either E-13, G-13 or F-63 showed no or modest cytotoxic activity on MCF-7 cells (
Intracellular ATP and Amino Acid Assays
Intracellular amino acid measurements were performed as described in Demetriades et al (
Cell Viability Assay Protocol
In Vitro TGR5 Activation Assay
Transfected cells were seeded in 96-well plates and incubated overnight with the compounds at increasing concentrations in duplicate. Lithocholic acid (LCA) at 10 µM was used as a positive reference compound. The cAMP-dependent luciferase expression was followed using the BrightGlo reagent according to the manufacturer (Promega) instructions. Luminescence was measured with a Mithras plate reader (Berthold). Data were expressed as percentage of the 10µM LCA value and EC 50 values were calculated using XL fit 5 software or GraphPad Prism 5.
Concentration-response curves were fitted by a nonlinear regression analysis to a 4 parameters logistic equation.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!